These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23670970)

  • 21. Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.
    Lewis JP; Palmer ND; Hicks PJ; Sale MM; Langefeld CD; Freedman BI; Divers J; Bowden DW
    Diabetes; 2008 Aug; 57(8):2220-5. PubMed ID: 18443202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis.
    Peng F; Hu D; Gu C; Li X; Li Y; Jia N; Chu S; Lin J; Niu W
    Gene; 2013 Dec; 531(2):435-43. PubMed ID: 24012816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.
    Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ
    Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of common type 2 diabetes risk gene variants on future type 2 diabetes in the non-diabetic population in Korea.
    Park SE; Lee WY; Oh KW; Baek KH; Yoon KH; Kang MI; Son HY; Lee WC
    J Hum Genet; 2012 Apr; 57(4):265-8. PubMed ID: 22377714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
    Moore AF; Jablonski KA; McAteer JB; Saxena R; Pollin TI; Franks PW; Hanson RL; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
    Diabetes; 2008 Sep; 57(9):2503-10. PubMed ID: 18544707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis.
    Blackman SM; Hsu S; Ritter SE; Naughton KM; Wright FA; Drumm ML; Knowles MR; Cutting GR
    Diabetologia; 2009 Sep; 52(9):1858-65. PubMed ID: 19585101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis.
    Sun L; Rommens JM; Corvol H; Li W; Li X; Chiang TA; Lin F; Dorfman R; Busson PF; Parekh RV; Zelenika D; Blackman SM; Corey M; Doshi VK; Henderson L; Naughton KM; O'Neal WK; Pace RG; Stonebraker JR; Wood SD; Wright FA; Zielenski J; Clement A; Drumm ML; Boëlle PY; Cutting GR; Knowles MR; Durie PR; Strug LJ
    Nat Genet; 2012 May; 44(5):562-9. PubMed ID: 22466613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.
    Hu C; Zhang R; Wang C; Wang J; Ma X; Lu J; Qin W; Hou X; Wang C; Bao Y; Xiang K; Jia W
    PLoS One; 2009 Oct; 4(10):e7643. PubMed ID: 19862325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci.
    Gong J; Wang F; Xiao B; Panjwani N; Lin F; Keenan K; Avolio J; Esmaeili M; Zhang L; He G; Soave D; Mastromatteo S; Baskurt Z; Kim S; O'Neal WK; Polineni D; Blackman SM; Corvol H; Cutting GR; Drumm M; Knowles MR; Rommens JM; Sun L; Strug LJ
    PLoS Genet; 2019 Feb; 15(2):e1008007. PubMed ID: 30807572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.
    Miller MR; Soave D; Li W; Gong J; Pace RG; Boëlle PY; Cutting GR; Drumm ML; Knowles MR; Sun L; Rommens JM; Accurso F; Durie PR; Corvol H; Levy H; Sontag MK; Strug LJ
    J Pediatr; 2015 May; 166(5):1152-1157.e6. PubMed ID: 25771386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
    Moheet A; Moran A
    J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis.
    Benrahma H; Charoute H; Lasram K; Boulouiz R; Atig RK; Fakiri M; Rouba H; Abdelhak S; Barakat A
    Biochem Genet; 2014 Oct; 52(9-10):430-42. PubMed ID: 24898818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan.
    Horikawa Y; Miyake K; Yasuda K; Enya M; Hirota Y; Yamagata K; Hinokio Y; Oka Y; Iwasaki N; Iwamoto Y; Yamada Y; Seino Y; Maegawa H; Kashiwagi A; Yamamoto K; Tokunaga K; Takeda J; Kasuga M
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3136-41. PubMed ID: 18477659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The solute carrier family 26 member 9 modifies rapidly progressing cystic fibrosis associated with homozygous F508del CFTR mutation.
    Luo S; Rollins S; Schmitz-Abe K; Tam A; Li Q; Shi J; Lin J; Wang R; Agrawal PB
    Clin Chim Acta; 2024 Jul; 561():119765. PubMed ID: 38852790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T2DM GWAS in the Lebanese population confirms the role of TCF7L2 and CDKAL1 in disease susceptibility.
    Ghassibe-Sabbagh M; Haber M; Salloum AK; Al-Sarraj Y; Akle Y; Hirbli K; Romanos J; Mouzaya F; Gauguier D; Platt DE; El-Shanti H; Zalloua PA
    Sci Rep; 2014 Dec; 4():7351. PubMed ID: 25483131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.
    Lin YC; Keenan K; Gong J; Panjwani N; Avolio J; Lin F; Adam D; Barrett P; Bégin S; Berthiaume Y; Bilodeau L; Bjornson C; Brusky J; Burgess C; Chilvers M; Consunji-Araneta R; Côté-Maurais G; Dale A; Donnelly C; Fairservice L; Griffin K; Henderson N; Hillaby A; Hughes D; Iqbal S; Itterman J; Jackson M; Karlsen E; Kosteniuk L; Lazosky L; Leung W; Levesque V; Maille É; Mateos-Corral D; McMahon V; Merjaneh M; Morrison N; Parkins M; Pike J; Price A; Quon BS; Reisman J; Smith C; Smith MJ; Vadeboncoeur N; Veniott D; Viczko T; Wilcox P; van Wylick R; Cutting G; Tullis E; Ratjen F; Rommens JM; Sun L; Solomon M; Stephenson AL; Brochiero E; Blackman S; Corvol H; Strug LJ
    Genet Med; 2021 May; 23(5):927-933. PubMed ID: 33500570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replication and Relevance of Multiple Susceptibility Loci Discovered from Genome Wide Association Studies for Type 2 Diabetes in an Indian Population.
    Phani NM; Adhikari P; Nagri SK; D'Souza SC; Satyamoorthy K; Rai PS
    PLoS One; 2016; 11(6):e0157364. PubMed ID: 27310578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients.
    Kmit A; Marson FAL; Pereira SV; Vinagre AM; Leite GS; Servidoni MF; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Amaral MD
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1323-1331. PubMed ID: 30716472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes.
    Hasan S; Soltman S; Wood C; Blackman SM
    J Clin Transl Endocrinol; 2022 Mar; 27():100287. PubMed ID: 34976741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.
    Iafusco F; Maione G; Rosanio FM; Mozzillo E; Franzese A; Tinto N
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33810109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.